| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |